Richard A. Heyman
CIK 1584759 · last filed 2026-07-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.20M
Companies
9
Total Filings
90
Lifetime Open-Market Net
-$1.58M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ORIC | Director | 254,572 | $11.91 | $3.03M | -$367.0K | 19 | 2026-07-08 |
| IMRA | Director | 149,218 | $14.49 | $2.16M | -$1.09M | 25 | 2026-02-19 |
| PMVP | Director | 975 | $1.10 | $1.1K | -$126.9K | 8 | 2025-06-09 |
| RayzeBio, Inc. (RYZB) Delisted | Director | 0 | $62.49 | $0 | $0 | 1 | 2024-02-27 |
| Metacrine, Inc. (MTCR) Delisted | Director | — | $0.49 | — | $0 | 2 | 2022-09-06 |
| Gritstone bio, Inc. (GRTS) Delisted | Director | — | $0.03 | — | $0 | 4 | 2022-06-22 |
| KINETA, INC./DE (YMTX) Delisted | Director | 1,160 | $13.23 | $15.3K | $0 | 3 | 2021-06-04 |
| Receptos, Inc. (RCPT) Delisted | Director | 0 | — | — | $0 | 3 | 2015-08-27 |
| VivoSim Labs, INC. (ONVO) Delisted | Director | — | $2.04 | — | $0 | 3 | 2015-08-24 |
Recent Filings · Page 2 of 9
90 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-16 | ORIC | Notice (144) | −7,000 | -$84.0K | EDGAR |
| 2026-01-12 | IMRA | Sell (S) | −13,920 | -$348.3K | EDGAR |
| 2026-01-08 | ELVN | Notice (144) | −1,620 | -$25.1K | EDGAR |
| 2026-01-08 | ELVN | Notice (144) | −12,300 | -$190.3K | EDGAR |
| 2026-01-06 | ORIC | Grant (A) | — | $0 | EDGAR |
| 2025-10-03 | ORIC | Exer (M) | +32,800 | $55.6K | EDGAR |
| 2025-06-09 | PMVP | Grant (A) | — | $0 | EDGAR |
| 2025-02-10 | IMRA | Grant (A) | — | $0 | EDGAR |
| 2025-01-06 | ORIC | Grant (A) | — | $0 | EDGAR |
| 2024-10-22 | IMRA | Sell (S) | −1,570 | -$47.1K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.